RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Mahavir Chougule to Alzheimer Disease

This is a "connection" page, showing publications Mahavir Chougule has written about Alzheimer Disease.
Connection Strength

0.635
  1. Alexander A, Agrawal M, Saraf S, Saraf S, Chougule MB. Formulation Strategies of Nano Lipid Carrier for Effective Brain Targeting of Anti-AD Drugs. Curr Pharm Des. 2020; 26(27):3269-3280.
    View in: PubMed
    Score: 0.439
  2. Agrawal M, Saraf S, Saraf S, Antimisiaris SG, Chougule MB, Shoyele SA, Alexander A. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs. J Control Release. 2018 07 10; 281:139-177.
    View in: PubMed
    Score: 0.098
  3. Agrawal M, Saraf S, Saraf S, Antimisiaris SG, Hamano N, Li SD, Chougule M, Shoyele SA, Gupta U, Alexander A. Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region. Expert Opin Drug Deliv. 2018 06; 15(6):589-617.
    View in: PubMed
    Score: 0.098
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support